Successful discontinuation of high-dose fluconazole for Histoplasma capsulatum meningitis in an AIDS patient after sustained immune reconstitution [11]

Clinical Infectious Diseases

Volumn 39, Issue 8, 2004, Pages 1261-1262

  Jenny Avital, Elizabeth ^a  

^a JACOBI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPHOTERICIN; ANTIRETROVIRUS AGENT; EFAVIRENZ; FLUCONAZOLE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIFUNGAL ACTIVITY; CLINICAL FEATURE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; LETTER; LYMPHOCYTE COUNT; MENINGITIS; MICROMORPHOLOGY; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOM; T LYMPHOCYTE; TRANSBRONCHIAL BIOPSY; TREATMENT FAILURE; TREATMENT WITHDRAWAL; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-RETROVIRAL AGENTS; ANTIFUNGAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; FLUCONAZOLE; HISTOPLASMOSIS; HUMANS; MENINGITIS, FUNGAL;

EID: 12844266757     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/424753     Document Type: Letter

References (3)

1. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis 2004; 38:1485-9.
2. Anaissie E, Fainstein V, Samo T, et al. Central nervous system histoplasmosis: an unappreciated complication of the Acquired Immunodeficiency Syndrome. Am J Med 1988; 84:215-7.
3. Weidenheim KM, Nelson SJ, Kure K, et al. Unusual patterns of Histoplasma capsulatum meningitis and progressive multifocal leukoencephalopathy in a patient with the acquired immunodeficiency virus. Hum Pathol 1992; 23: 581-6.